AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,554,290 | +1.5% | 50,500 | -6.3% | 0.00% | 0.0% |
| Q2 2023 | $2,516,171 | +65.8% | 53,891 | +35.8% | 0.00% | +100.0% |
| Q1 2023 | $1,517,927 | -29.9% | 39,674 | +0.4% | 0.00% | -33.3% |
| Q4 2022 | $2,165,477 | +74.8% | 39,516 | +8.6% | 0.00% | +50.0% |
| Q3 2022 | $1,239,000 | +342.5% | 36,386 | +22.7% | 0.00% | – |
| Q2 2022 | $280,000 | -20.7% | 29,663 | +19.1% | 0.00% | – |
| Q1 2022 | $353,000 | -38.8% | 24,908 | -8.7% | 0.00% | -100.0% |
| Q4 2021 | $577,000 | -3.4% | 27,274 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $597,000 | -32.2% | 26,721 | -24.7% | 0.00% | 0.0% |
| Q2 2021 | $880,000 | +48.1% | 35,465 | +73.1% | 0.00% | 0.0% |
| Q1 2021 | $594,000 | +12.3% | 20,489 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $529,000 | -16.2% | 20,489 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $631,000 | +50.2% | 20,489 | +21.5% | 0.00% | 0.0% |
| Q2 2020 | $420,000 | +55.6% | 16,866 | +32.6% | 0.00% | 0.0% |
| Q1 2020 | $270,000 | +63.6% | 12,723 | +70.8% | 0.00% | – |
| Q4 2019 | $165,000 | -2.4% | 7,447 | 0.0% | 0.00% | – |
| Q3 2019 | $169,000 | – | 7,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |